Skip to content

Flow-Controlled Versus Volume-Controlled Ventilation in Lumbar Disc Herniation Surgery

Comparison of Flow-Controlled and Volume-Controlled Ventilation During Lumbar Disc Herniation Surgery: A Prospective Randomized Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07614555
Enrollment
80
Registered
2026-05-29
Start date
2026-05-28
Completion date
2026-11-26
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Disc Herniation Surgery, Mechanical Ventilation

Keywords

Flow-Controlled Ventilation, Volume-Controlled Ventilation, Lumbar Disc Herniation Surgery

Brief summary

This prospective randomized trial aims to compare the effects of flow-controlled ventilation (FCV) and volume-controlled ventilation (VCV) on intraoperative airway pressures and oxygenation in patients undergoing lumbar disc herniation surgery under general anesthesia. Adult patients aged 18-65 years, with ASA physical status I-III and a body mass index of 18-30 kg/m², will be allocated to receive either FCV or VCV during routine intraoperative mechanical ventilation. Ventilatory parameters, including peak airway pressure, plateau pressure, pulmonary compliance, EtCO₂, SpO₂, and arterial blood gas variables, will be recorded at predefined time points after intubation. The primary endpoint is the PaO₂ value measured after 20 minutes in the prone position. By comparing respiratory mechanics and oxygenation between the two ventilation modes, this study aims to contribute to the optimization of intraoperative ventilatory management in lumbar disc herniation surgery.

Interventions

PROCEDUREFCV Group

Patients allocated to the FCV group will receive intraoperative mechanical ventilation using a flow-controlled ventilation mode during surgery under general anesthesia. Patients will be started on ventilation after intubation with 50% oxygen, driving pressure 12, PEEP 5, and a 1:1 inspiration/expiratory ratio.

PROCEDUREVCV Group

Patients allocated to the VCV group will receive intraoperative mechanical ventilation using a conventional volume-controlled ventilation mode throughout surgery under general anesthesia. Patients will be started on ventilation after intubation with 50% oxygen, 7 ml/ideal body weight tidal volume, PEEP 5, 12 breaths per minute frequency, and a 1:2 inspiration/expiration ratio.

Sponsors

Ankara Etlik City Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 65 years * ASA physical status I-III * Body Mass Index between 18 and 30 kg/m²

Exclusion criteria

* Age \< 18 years or \> 65 years * Known or previously diagnosed pulmonary disease * Patients with severe preoperative pulmonary function impairment (e.g., FEV₁ \< 50% predicted, severe restrictive or obstructive pathology) * Patients with markedly altered lung anatomy or function due to prior major thoracic surgery * Patients who were dependent on supplemental oxygen therapy in the preoperative period * ASA physical status IV or higher * Refusal or inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
The PaO₂ measured 20 minutes after prone position.20 minutes after the prone position, in the intraoperative period.The primary outcome measure will be the PaO₂ derived from arterial blood gas analysis at 20 minutes after the prone position.

Secondary

MeasureTime frameDescription
The PaO₂ measured during perioperative periodDay 1The PaO₂ values will be measured and recorded using arterial blood gas analysis.
Peak airway pressure (Ppeak) values during perioperative periodDay 1Ppeak will be measured and recorded.
Plateau airway pressure (Pplateau) values during perioperative periodDay 1Pplateau will be measured and recorded.

Countries

Turkey (Türkiye)

Contacts

CONTACTAtakan Sezgi
kansezgi@gmail.com00905323327000
CONTACTMusa Zengin
musazengin@gmail.com00905307716235

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 2, 2026